Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis

Fig. 4

The differences in OS between the low-and high- risk groups based on the median risk score and ROC curve predict survival in TCGA and ICGC datasets. a-b significant differences in OS between the two categories (c-d) Kaplan–Meier overall survival (OS) curves for patients predicting 3 years survival in the TCGA (c) and ICGC (d) datasets assigned to high- and low-risk groups based on the risk score

Back to article page